Truffle’s portfolio company Carmat SAS, a French company that’s developing an artificial heart, successfully completed an IPO yesterday above its target. The IPO will allow the company, founded in 2008, to complete pre-clinical trials on the artificial heart and start testing the device on humans. The implantable organ closely resembles a human heart, featuring right […]